Kidney graft failure is not a homogenous disease and the Banff classification distinguishes
several types of graft rejection. The maintenance of a transplant and the treatment of its …

Despite significant advancements in immunosuppressive therapies, kidney transplant
rejection continues to pose a substantial challenge, impacting the long-term survival of …

Introduction Antibody-mediated rejection (ABMR) is a leading cause of kidney allograft
failure. Its therapy continues to be challenge, and no treatment has been approved for the …

Introduction Kidney transplant rejection remains an important clinical problem despite the
development of effective immunosuppressive therapy. Two major types of rejection are …

Chronic rejection in renal transplantation clinically manifests as slow deterioration in
allograft function and is a major contributor of late renal graft loss. Most cases of chronic …

ABMR is the leading cause of kidney allograft failure. The recent expansion of its spectrum is
related to the paradigm of a continuous process, leading insidiously to a chronic form of …

We studied diverse rejection management strategies across centers by conducting a UNOS
survey of kidney transplant program directors in 2017. There were 104 total responses from …

Over the last decades early rejection rates decreased, the majority of T cell mediated
rejections (TCMR) respond to treatment [1, 2], and Banff borderline category is the most …

Introduction: Acute antibody-mediated rejection (AMR) in renal-transplant recipients is
generally less responsive to conventional antirejection therapy and has a worse prognosis …

The ability to personalize management for a given kidney transplant recipient and identify
treatments that will improve their long-term outcome remains a critical unmet need. Earlier …